Orphan - PDFSEARCH.IO - Document Search Engine

Orphan
Results: 2539

#	Item
241	What Have Sequencing Trials Taught Us? Cora N. Sternberg, MD, FACP Department of Medical Oncology San Camillo and Forlanini Hospitals Rome, Italy Add to Reading List Source URL: www.euikcs.com Language: English - Date: 2015-05-04 13:05:45 Macrolides Organofluorides Orphan drugs Pyridines Immunosuppressants Renal cell carcinoma Temsirolimus Sunitinib Vascular endothelial growth factor Chemistry Organic chemistry Medicine
242	Genetic and Rare Disorders Organisation NEWSLETTERGENETIC AND RARE Add to Reading List Source URL: www.grdo.ie Language: English - Date: 2012-06-12 12:05:44 Rare diseases European Organization for Rare Diseases Rare Disease Day Clinical research Orphan drug Medical genetics Disease Genetic counseling Genetic Alliance UK Health Medicine Epidemiology
243	Prologue (to Before the First Snow by Walter M. Brasch) There was nothing distinguished or distinguishing about Bill Drumheller. Ask ten witnesses to describe him to a police sketch artist, Add to Reading List Source URL: www.walterbrasch.com Language: English - Date: 2011-10-14 20:30:30 James Whitcomb Riley Little Orphan Annie Comics
244	DOI Outreach meeting- MilanThe importance of Standard Ids in FORWARD and RDI projects Gabriella Scipione Add to Reading List Source URL: www.doi.org Language: English - Date: 2015-01-13 21:44:49 Identifiers International Standard Audiovisual Number Orphan works ISO standards Universal identifiers International Standard Name Identifier
245	CORPORATE FACT SHEET December 2013 Acceleron is a biopharmaceutical company committed to discover, develop, manufacture and commercialize novel protein therapeutics for cancer and orphan diseases Acceleron’s scientific Add to Reading List Source URL: www.acceleronpharma.com Language: English - Date: 2013-12-03 10:00:27 Hematology Anemias Hematopathology Celgene Myelodysplastic syndrome Beta-thalassemia Transforming growth factor beta Thalassemia Diamond–Blackfan anemia Medicine Health Biology
246	Corporate Presentation April 2015 Forward-looking statements This document does not constitute or form part of any offer or invitation to sell or issue, or any solicitation of any offer to purchase or subscribe for, any Add to Reading List Source URL: www.tigenix.com Language: English - Date: 2015-04-23 07:59:35 Biotechnology Cloning Cell therapy Emerging technologies Peripheral blood mononuclear cell Mesenchymal stem cell Swedish Orphan Biovitrum Tissue engineering Pharmaceutical industry Biology Stem cells Cell biology
247	TiGenix Investment highlights An advanced biopharmaceutical company focused on developing and commercialising Add to Reading List Source URL: www.tigenix.com Language: English - Date: 2015-04-23 08:03:15 Stem cells Cell biology Cell therapy Swedish Orphan Biovitrum Adipose tissue Stem cell Pharmaceutical industry Biologic Biopharmaceutical Biology Biotechnology Pharmacology
248	Award ID: CC121004 Project Title: Biobetter Cancer Monoclonal Antibody Program Award Mechanism: Company Commercialization Add to Reading List Source URL: www.cprit.state.tx.us Language: English - Date: 2015-03-24 12:30:05 Pharmacology Orphan drugs Monoclonal antibody therapy Bevacizumab Trastuzumab Monoclonal antibodies B-cell chronic lymphocytic leukemia Medicine Immunology Immune system
249	Case 1:14-cvRC Document 14 FiledPage 1 of 2 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF COLUMBIA PHARMACEUTICAL RESEARCH AND Add to Reading List Source URL: www.fdalawblog.net Language: English - Date: 2015-03-13 09:57:22 Medicine Pharmacology Food and Drug Administration Drug discovery Orphan drug Healthcare Systems Bureau Orphan Drug Act Pharmaceutical industry Rare disease Pharmaceutical sciences Health Pharmaceuticals policy
250	“A valuable opportunity to meet others in the rare disease space, and learn about, and from, the various aspects and challenges each deals with.” – Richard Klein, Director, Patient Liaison Program, Office of Healt Add to Reading List Source URL: www.pmaconference.com Language: English - Date: 2015-05-05 12:13:10 Medicine Drug discovery Epidemiology Nursing research Pharmaceutical industry Orphan drug Clinical trial Rare disease Food and Drug Administration Health Pharmaceutical sciences Pharmacology

UPDATE